239
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence and Predictors of Remission and Sustained Remission in Patients with Rheumatoid Arthritis from the United Arab Emirates: A Two-Year Prospective Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 51-63 | Received 21 Feb 2023, Accepted 05 May 2023, Published online: 10 May 2023

References

  • Ajeganova S, Huizinga T. Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations. Ther Adv Musculoskelet Dis. 2017;9(10):249–262. doi:10.1177/1759720X17720366
  • Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001. doi:10.1038/nrdp.2018.1
  • Yu C, Jin S, Wang Y, et al. Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis. Clin Rheumatol. 2019;38(3):727–738. doi:10.1007/s10067-018-4340-7
  • Aga AB, Lie E, Uhlig T, et al. Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Ann Rheum Dis. 2015;74(2):381–388. doi:10.1136/annrheumdis-2013-204020
  • Overman CL, Jurgens MS, Bossema ER, Jacobs JW, Bijlsma JW, Geenen R. Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades. Arthritis Care Res. 2014;66(5):671–678. doi:10.1002/acr.22211
  • England BR, Tiong BK, Bergman MJ, et al. 2019 update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res. 2019;71(12):1540–1555. doi:10.1002/acr.24042
  • Littlejohn G, Roberts L, Bird P, et al. Patients with rheumatoid arthritis in the Australian OPAL Cohort show significant improvement in disease activity over 5 years: a multicenter observational study. J Rheumatol. 2015;42(9):1603–1609. doi:10.3899/jrheum.141575
  • Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. doi:10.1136/annrheumdis-2019-216655
  • Schett G, Tanaka Y, Isaacs JD. Why remission is not enough: underlying disease mechanisms in RA that prevent cure. Nat Rev Rheumatol. 2021;17(3):135–144. doi:10.1038/s41584-020-00543-5
  • Cook MJ, Diffin J, Scire CA, et al. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology. 2016;55(9):1601–1609. doi:10.1093/rheumatology/kew210
  • Furst DE, Pangan AL, Harrold LR, et al. Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry. Arthritis Care Res. 2011;63(6):856–864. doi:10.1002/acr.20452
  • Gremese E, Salaffi F, Bosello SL, et al. Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann Rheum Dis. 2013;72(6):858–862. doi:10.1136/annrheumdis-2012-201456
  • Jawaheer D, Messing S, Reed G, et al. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients. Arthritis Care Res. 2012;64(12):1811–1818. doi:10.1002/acr.21762
  • Jayakumar K, Norton S, Dixey J, et al. Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology. 2012;51(1):169–175. doi:10.1093/rheumatology/ker250
  • Lee KE, Choi SE, Xu H, Kang JH, Park DJ, Lee SS. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis. Rheumatol Int. 2017;37(12):2027–2034. doi:10.1007/s00296-017-3833-z
  • Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2016;68(1):1–25. doi:10.1002/acr.22783
  • Sung YK, Yoshida K, Prince FHM, et al. Prevalence and predictors for sustained remission in rheumatoid arthritis. PLoS One. 2019;14(4):e0214981. doi:10.1371/journal.pone.0214981
  • Xie W, Li J, Zhang X, Sun X, Zhang Z. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018. Int J Rheum Dis. 2019;22(9):1670–1678. doi:10.1111/1756-185X.13651
  • Pope JE, Movahedi M, Rampakakis E, et al. ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). RMD Open. 2018;4(2):e000738. doi:10.1136/rmdopen-2018-000738
  • Halabi H, Alarfaj A, Alawneh K, et al. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East. Int J Rheum Dis. 2015;18(3):268–275. doi:10.1111/1756-185X.12320
  • Sun X, Li R, Cai Y, et al. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region. Lancet Reg Health West Pac. 2021;15:100240. doi:10.1016/j.lanwpc.2021.100240
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
  • Anderson JK, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, Disease Activity Score (DAS) and disease activity score with 28-joint counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res. 2011;63(Suppl 11):S14–36. doi:10.1002/acr.20621
  • Maska L, Anderson J, Michaud K. Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res. 2011;63(Suppl 11):S4–13. doi:10.1002/acr.20620
  • Takanashi S, Kaneko Y, Takeuchi T. CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice. Ann Rheum Dis. 2020;79(5):671–674. doi:10.1136/annrheumdis-2019-216607
  • Balsa A, de Miguel E, Castillo C, Peiteado D, Martin-Mola E. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology. 2010;49(4):683–690. doi:10.1093/rheumatology/kep442
  • Salaffi F, Di Carlo M, Farah S, Marotto D, Atzeni F, Sarzi-Puttini P. Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures. Acta Biomed. 2021;92(4):e2021238. doi:10.23750/abm.v92i4.10831
  • Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63(3):573–586. doi:10.1002/art.30129
  • Acosta-Merida A, Naranjo A, Rodriguez-Lozano C. Prognostic factors for sustained remission in a “real life” cohort of rheumatoid arthritis patients. Reumatol Clin. 2020;16(5 Pt 2):405–409. doi:10.1016/j.reuma.2018.10.002
  • Zafar S, Badsha H, Mofti A, et al. Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis. J Clin Rheumatol. 2012;18(6):279–282. doi:10.1097/RHU.0b013e3182676975
  • Contreras-Yanez I, Pascual-Ramos V. Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters. Arthritis Res Ther. 2015;17:177. doi:10.1186/s13075-015-0697-z
  • Norton S, Fu B, Scott DL, et al. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum. 2014;44(2):131–144. doi:10.1016/j.semarthrit.2014.05.003
  • Almoallim H, Hassan R, Cheikh M, et al. Rheumatoid Arthritis Saudi Database (RASD): disease characteristics and remission rates in a tertiary care center. Open Access Rheumatol. 2020;12:139–145. doi:10.2147/OARRR.S260426
  • Einarsson JT, Geborek P, Saxne T, Kristensen LE, Kapetanovic MC. Sustained remission improves physical function in patients with established rheumatoid arthritis, and should be a treatment goal: a prospective observational cohort study from Southern Sweden. J Rheumatol. 2016;43(6):1017–1023. doi:10.3899/jrheum.150995
  • van Nies JA, de Jong Z, van der Helm-van Mil AH, Knevel R, Le Cessie S, Huizinga TW. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology. 2010;49(11):2210–2216. doi:10.1093/rheumatology/keq250
  • Mohammed RH, Farahat F, Kewan HH, Bukhari MA. Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease. Springerplus. 2015;4:207. doi:10.1186/s40064-015-0979-6
  • Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M. Demographic and clinical patterns of rheumatoid arthritis in an Emirati Cohort from United Arab Emirates. Int J Rheumatol. 2019;2019:3057578. doi:10.1155/2019/3057578
  • Wong PK. Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe? Rheumatol Int. 2016;36(11):1535–1542. doi:10.1007/s00296-016-3566-4
  • van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012;8(4):337–351. doi:10.1586/eci.12.23
  • Curtis JR, Bykerk VP, Aassi M, Schiff M. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J Rheumatol. 2016;43(11):1997–2009. doi:10.3899/jrheum.151212
  • De Vera MA, Mailman J, Galo JS. Economics of non-adherence to biologic therapies in rheumatoid arthritis. Curr Rheumatol Rep. 2014;16(11):460. doi:10.1007/s11926-014-0460-5
  • Heidari P, Cross W, Weller C, Nazarinia M, Crawford K. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: a cross-sectional study. Int J Rheum Dis. 2019;22(4):555–566. doi:10.1111/1756-185X.13549
  • Roodenrijs NMT, van der Goes MC, Welsing PMJ, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology. 2021;60(8):3778–3788. doi:10.1093/rheumatology/keaa860
  • Pascual-Ramos V, Contreras-Yanez I, Villa AR, Cabiedes J, Rull-Gabayet M. Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability. Arthritis Res Ther. 2009;11(1):R26. doi:10.1186/ar2620
  • Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004;43(7):906–914. doi:10.1093/rheumatology/keh199
  • Matcham F, Davies R, Hotopf M, et al. The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatology. 2018;57(5):835–843. doi:10.1093/rheumatology/kex528
  • Tornero-Molina J, Sanchez-Alonso F, Fernandez-Prada M, Bris-Ochaita ML, Sifuentes-Giraldo A, Vidal-Fuentes J. Tele-rheumatology during the COVID-19 pandemic. Reumatol Clin. 2022;18(3):157–163. doi:10.1016/j.reuma.2020.10.004
  • Chevallard M, Belloli L, Ughi N, et al. Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting. Rheumatol Int. 2021;41(7):1253–1261. doi:10.1007/s00296-021-04863-x